DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Journey Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$5.17+0.21 (+4.13%)
Close on Oct 19, 2026
- Market cap
- $142.14M
- P/E (TTM)
- –
- Dividend yield
- –
Journey Medical Corp revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q4 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emrosi | $24.21M | $18.93M | $14.75M | – | – | – | – | – | – | – | – | – | 35.5% | – |
| Qbrexza | $23.05M | $24.88M | $25.01M | $25.15M | $25.37M | $25.26M | $25.11M | $26.81M | $25.09M | $26.33M | $25.41M | – | 33.8% | -9.2% |
| Accutane | $12.51M | $12.54M | $12.88M | $13.69M | $14.92M | $17.24M | $19.41M | $20.59M | $21.48M | $21.34M | $20.17M | $10.05M | 18.3% | -16.2% |
| Foam franchise products (Amzeeq & Zilxi) | $5.19M | $5.38M | $5.86M | $5.92M | $6.71M | – | $6.65M | – | – | – | – | – | 7.6% | -22.7% |
| Other / legacy | $1.79M | $2.29M | $2.74M | $3.28M | $3.53M | $3.52M | $3.96M | $3.98M | $4.54M | $5.17M | $5.92M | – | 2.6% | -49.4% |
| Ximino | – | – | – | – | – | – | – | – | – | – | – | $8.25M | – | – |
| Exelderm | – | – | – | – | – | – | – | – | – | – | – | $5.36M | – | – |
| Other branded revenue | – | – | – | – | – | – | – | – | – | – | – | $37.00K | – | – |
| Targadox | – | – | – | – | – | – | – | – | – | – | – | $22.38M | – | – |
| Qbrexa | – | – | – | – | – | – | – | – | – | – | – | $17.06M | – | – |
| Zilxi | – | – | – | – | $1.68M | $1.80M | $1.64M | $1.60M | $1.72M | $1.92M | $1.96M | – | – | – |
| Amzeeq | – | – | – | – | $5.03M | $5.35M | $5.01M | $4.80M | $5.59M | $5.76M | $6.20M | – | – | – |
By region
From the segment and revenue-disaggregation notes of Journey Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.